DE69231486D1 - Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung - Google Patents

Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung

Info

Publication number
DE69231486D1
DE69231486D1 DE69231486T DE69231486T DE69231486D1 DE 69231486 D1 DE69231486 D1 DE 69231486D1 DE 69231486 T DE69231486 T DE 69231486T DE 69231486 T DE69231486 T DE 69231486T DE 69231486 D1 DE69231486 D1 DE 69231486D1
Authority
DE
Germany
Prior art keywords
regeneration
dexamethasone
composition containing
tissue repair
pdgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231486T
Other languages
English (en)
Other versions
DE69231486T2 (de
Inventor
Robert Bruce Rutherford
Marc F Charette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut
Creative Biomolecules Inc
Original Assignee
University of Connecticut
Creative Biomolecules Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Connecticut, Creative Biomolecules Inc filed Critical University of Connecticut
Publication of DE69231486D1 publication Critical patent/DE69231486D1/de
Application granted granted Critical
Publication of DE69231486T2 publication Critical patent/DE69231486T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69231486T 1991-03-12 1992-03-12 Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung Expired - Fee Related DE69231486T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/669,070 US5149691A (en) 1991-03-12 1991-03-12 Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
PCT/US1992/002043 WO1992016181A2 (en) 1991-03-12 1992-03-12 Composition for promoting tissue repair and regeneration

Publications (2)

Publication Number Publication Date
DE69231486D1 true DE69231486D1 (de) 2000-11-02
DE69231486T2 DE69231486T2 (de) 2001-04-26

Family

ID=24684879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231486T Expired - Fee Related DE69231486T2 (de) 1991-03-12 1992-03-12 Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung

Country Status (8)

Country Link
US (2) US5149691A (de)
EP (1) EP0575484B1 (de)
JP (1) JPH07505858A (de)
AT (1) ATE196604T1 (de)
AU (1) AU656372B2 (de)
CA (1) CA2106073C (de)
DE (1) DE69231486T2 (de)
WO (1) WO1992016181A2 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US7384634B2 (en) * 1991-08-30 2008-06-10 University Of South Florida Connective tissue growth factor
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5444151A (en) * 1992-05-15 1995-08-22 Ludwig Institute For Cancer Research Platelet derived growth factor antagonists
US5326695A (en) * 1992-05-15 1994-07-05 Ludwig Institute For Cancer Research Platelet derived growth factor agonists
DE4228457A1 (de) * 1992-08-27 1994-04-28 Beiersdorf Ag Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
US5455041A (en) * 1993-09-13 1995-10-03 Research Foundation Of State University Of New York At Buffalo Method for inducing periodontal tissue regeneration
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
EP0743066A3 (de) * 1995-05-16 1998-09-30 Mitsui Pharmaceuticals, Inc. Wundheilmittel
US5776193A (en) * 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
US6902584B2 (en) 1995-10-16 2005-06-07 Depuy Spine, Inc. Bone grafting matrix
WO1997045533A1 (en) * 1996-05-28 1997-12-04 The Regents Of The University Of Michigan Engineering oral tissues
DE19754140A1 (de) * 1997-12-05 1999-06-24 Era Beschichtung Gmbh & Co Kg Innenraummaterial auf der Basis von Kunststoff, Verfahren zu dessen Herstellung und Verwendung desselben
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
AU1430601A (en) * 1999-11-02 2001-05-14 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
WO2002070731A2 (en) 2001-03-05 2002-09-12 Visible Genetics Inc. Methods and primers for evaluating hiv-1 mutations
EP1531837A4 (de) * 2001-06-07 2006-11-15 Chiou Consulting Inc ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE PROPHYLAXE UND BEHANDLUNG VON APHTHEN UND HERPES-SIMPLEX-LÄSIONEN
US7819888B2 (en) * 2001-10-23 2010-10-26 Innovasive Devices, Inc. Method and apparatus for harvesting and implanting bone plugs
DE10152956A1 (de) * 2001-10-26 2003-05-15 Fresenius Kabi De Gmbh Pharmazeutische Zusammensetzung, einen Wachstumsfaktor und/oder ein Zytokin und ein antiseptisches Biguanid umfassend
JP2005530768A (ja) * 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
US20040018220A1 (en) * 2002-07-26 2004-01-29 Chiou Consulting, Inc. Aqueous compositions for facial cosmetics
US6616923B1 (en) * 2002-07-26 2003-09-09 Chiou Consulting, Inc. Aqueous compositions for facial cosmetics
CA2518667C (en) 2003-03-14 2011-07-19 The Trustees Of Columbia University In The City Of New York Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
US20060076295A1 (en) 2004-03-15 2006-04-13 The Trustees Of Columbia University In The City Of New York Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
US7309232B2 (en) * 2003-10-10 2007-12-18 Dentigenix Inc. Methods for treating dental conditions using tissue scaffolds
US7258875B2 (en) * 2003-12-04 2007-08-21 Chiou Consulting, Inc. Compositions and methods for topical treatment of skin infection
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
GB0414803D0 (en) * 2004-07-01 2004-08-04 Glaxo Group Ltd Composition
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US20060115266A1 (en) * 2004-12-01 2006-06-01 Gil Levi All-optical protection signaling systems and methods in optical communication networks
WO2007016620A2 (en) * 2005-08-01 2007-02-08 Genera Doo Methods and compositions for regenerating articular cartilage
CA2630077C (en) 2005-11-17 2014-07-15 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP1976864B1 (de) 2006-01-23 2012-09-26 Imagene Co., Ltd. Neues peptid und seine verwendung
EP2311505B1 (de) * 2006-02-09 2013-11-06 BioMimetic Therapeutics, LLC Zusammensetzungen und Verfahren zur Behandlung von Knochen
JP2010506599A (ja) 2006-05-22 2010-03-04 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 第１流体と第２流体との間で成分を交換する方法、第１流体から第１成分を清浄する方法、血液の処理方法、流体処理装置、第１流体と第１及び第２成分を含む第２流体との間で成分を交換する装置、第１流体と第２流体との間で成分を交換する装置、血漿から血球を分離する方法
AU2007269712B2 (en) 2006-06-30 2013-02-07 Biomimetic Therapeutics, Llc PDGF-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
AU2013203287B2 (en) * 2006-11-03 2015-12-17 Biomimetic Therapeutics, Llc. Compositions and methods for arthrodetic procedures
US9511076B2 (en) * 2008-05-30 2016-12-06 Clarion Research Group Formulations and methods for recovery from dental surgery
US8282963B2 (en) * 2007-10-15 2012-10-09 The Regents Of The University Of Colorado, A Body Corporate Methods for extracting platelets and compositions obtained therefrom
MX2010007442A (es) 2008-01-07 2010-12-21 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Uso de peptidos para promover la curacion de heridas.
WO2009100154A1 (en) 2008-02-04 2009-08-13 Trustees Of Columbia University In The City Of New York Fluid separation devices, systems and methods
RU2010137106A (ru) 2008-02-07 2012-03-20 Байомайметик Терапьютикс, Инк. (Us) Композиции и способы для дистракциионного остеогенеза
EP2341951A2 (de) 2008-09-09 2011-07-13 BioMimetic Therapeutics, Inc. Aus thrombozyten stammende wachstumsfaktor-zusammensetzungen und verfahren zur behandlung von sehnen- und bänderverletzungen
US20120100111A1 (en) * 2009-03-06 2012-04-26 Universite Paris Descartes Method for treating cancer
CN102811622A (zh) 2010-02-22 2012-12-05 生物模拟治疗公司 用于治疗腱病的血小板衍生生长因子组合物和方法
AU2011267081A1 (en) 2010-06-14 2013-01-17 Gene Signal International Sa Novel peptides for wound healing
US8288334B2 (en) 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
ES2410804T3 (es) 2010-06-14 2013-07-03 Gene Signal International Sa Péptidos para la curación de heridas
WO2012021249A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
US20130108683A1 (en) * 2011-10-25 2013-05-02 Biomimetic Therapeutics, Inc. Compositions and methods for treating partial and full thickness wounds and injuries
EP2814514B1 (de) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates
JP6871855B2 (ja) 2014-10-14 2021-05-19 サムエル リンチ， 創傷を処置するための組成物
AU2018256435A1 (en) 2017-04-20 2019-11-07 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
KR20200060997A (ko) 2018-11-23 2020-06-02 (주)메디코스바이오텍 창상치료용 약학조성물
CZ308845B6 (cs) 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran
PL433169A1 (pl) 2020-03-06 2021-09-13 Gdański Uniwersytet Medyczny Lipopeptydowe koniugaty i ich sole, sposób wytwarzania lipopeptydowych koniugatów i ich soli, kompozycja farmaceutyczna zawierająca lipopeptydowy koniugat i jego sole do leczenia ran przewlekłych

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
US4957742A (en) * 1984-11-29 1990-09-18 Regents Of The University Of Minnesota Method for promoting hair growth
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
EP0292517B1 (de) * 1986-12-11 1992-09-09 Btg International Limited Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
AU657472B2 (en) * 1990-03-06 1995-03-16 Claude Paul Genero Towel or blanket support device
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
CA2108120C (en) * 1991-04-12 1997-03-25 Marc F. Charette Method of treating gastrointestinal ulcers with platelet derived growth factor

Also Published As

Publication number Publication date
US5149691A (en) 1992-09-22
WO1992016181A3 (en) 1992-11-12
EP0575484A1 (de) 1993-12-29
ATE196604T1 (de) 2000-10-15
CA2106073A1 (en) 1993-09-13
AU656372B2 (en) 1995-02-02
WO1992016181A2 (en) 1992-10-01
CA2106073C (en) 2003-09-30
EP0575484B1 (de) 2000-09-27
US5376636A (en) 1994-12-27
DE69231486T2 (de) 2001-04-26
JPH07505858A (ja) 1995-06-29
AU1559192A (en) 1992-10-21

Similar Documents

Publication Publication Date Title
DE69231486D1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung
DE69230344D1 (de) Zusammensetzungen und methoden zur wundbehandlung
ATE88899T1 (de) Wundheilung und knochenregeneration.
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
DE3482754D1 (de) Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung.
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
DE69535976D1 (de) Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
DE69902234T2 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ATE71294T1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
DE68905342D1 (de) Verwendung von minoxidil zur wundheilung.
DE3879949D1 (de) Stimulierung von makrophagen durch homologe oder analoge von quadrol.
ES540447A0 (es) Un metodo de preparar un vendaje
NO933742L (no) Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69831336D1 (de) Tazaroten und uvb-phototherapie zur behandlung von psoriasis
JPS63215631A (ja) 創傷治療剤
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
ATE253945T1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden
NO940406L (no) Preparat og fremgangsmåte for behandling av sårskader
RU95119300A (ru) Средство для лечения длительно незаживающих ран

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee